Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methylxanthines are a class of chemical compounds derived from xanthine with one or more methyl groups attached to their structure. They are found naturally in various plants and have significant pharmacological properties, acting as phosphodiesterase inhibitors, adenosine receptor antagonists, and influencing calcium regulation and histone deacetylase activity. They are used therapeutically in respiratory conditions and as CNS stimulants but have a narrow therapeutic window and potential for toxicity.
Methylxanthines exert their effects through multiple mechanisms including phosphodiesterase inhibition, adenosine receptor antagonism, histone deacetylase activation, calcium regulation, and GABA receptor modulation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methylxanthines.